The molecular biology and biotechnology fields are growing by leaps and bounds. Molecular
Biosafety aims to shed light on how these cutting-edge techniques impact safety. Please
e-mail any comments, suggestions, or insights to Margy Lambert at margylambert@gmail.com.
FlemmingHC, WingenderJ. The biofilm matrix. Nat Rev Microbiol. 2010; 8(9):623–33.
3.
HwangIY, TanMH, KohE, HoCL, PohCL, ChangMW. Reprogramming microbes to be pathogen-seeking killers. ACS Synth Biol. Epub September 13, 2013.
4.
LambertMS. An update on antibiotic alternatives—old and new
strategies. Appl Biosafety. 2011; 16(3):184–7.
5.
OelschlaegerT. Mechanisms of probiotic actions—a review. Int J
Med Microbiol. 2010; 300(1):57–62.
6.
PattaniR, PaldaVA, HwangSW, ShahPS. Probiotics for the prevention of antibiotic-associated diarrhea and
Clostridium difficile infection among hospitalized patients:
Systematic review and meta-analysis. Open Med. 2013; 7(2):e56–67.
7.
QuigleyEM. Prebiotics and probiotics: Modifying and mining the
microbiota. Pharmacol Res.: The Official Journal of the Italian
Pharmacological Society. 2010; 61(3):213–8.
8.
SaeidiN, WongCK, LoTM, NguyenHX, LingH, LeongSS. Engineering microbes to sense and eradicate Pseudomonas
aeruginosa, a human pathogen. Mol Sys Biol. 2011; 7:521.
9.
SikosrskaH, SmoragiewiczW. Role of probiotics in the prevention and treatment of
Staphylococcus aureus infections. Int J
Antimicrob Agents. 2013; 42(6):475–81.
10.
WakiN, YajimaN, SuganumaH, BuddleBM, LuoD, HeiserA, ZhengT. Oral administration of Lactobacillus brevis KB290 to
mice alleviates clinical symptoms following influenza virus infection. Let Appl Microbiol. 2014; 58(1):87–93.
